Shareholders Target Lilly Over Zyprexa
Eli Lilly and Co. has come under legal fire again over Zyprexa, this time from shareholders who claim the pharmaceutical giant engaged in an illicit scheme to conceal the side effects...To view the full article, register now.
Already a subscriber? Click here to view full article